Literature DB >> 30211108

Small Cell Neuroendocrine Carcinoma: A Rare Nasopharyngeal Malignancy with Aggressive Clinical Course.

Nishu Bhardwaj1, Aanchal Kakkar1, David Victor Kumar Irugu2.   

Abstract

Primary small cell neuroendocrine carcinoma is uncommon in head and neck region, with occasional cases in nasopharynx. Distinction from other round cell tumors is imperative to ensure optimal patient management. We present a case of a 30-year-old woman who presented with a rapidly growing nasopharyngeal mass.

Entities:  

Keywords:  Immunohistochemistry; Nasopharynx; Small cell carcinoma

Year:  2018        PMID： 30211108      PMCID： PMC6127052          DOI： 10.1007/s12070-018-1344-1

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN： 2231-3796


  18 in total

1.  Sinonasal neuroendocrine carcinoma presenting as a nasopharyngeal mass.

Authors:  H Galera-Ruiz; J L Villar-Rodriguez; J A Sanchez-Calzado; J Martin-Mora; E Ruiz-Carmona
Journal:  Otolaryngol Head Neck Surg       Date:  2001-04       Impact factor: 3.497

Review 2.  Immunohistochemical analysis of small cell carcinoma of the head and neck: a report of four patients and a review of sixteen patients in the literature with ectopic hormone production.

Authors:  H Mineta; K Miura; S Takebayashi; K Araki; Y Ueda; H Harada; K Misawa
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-01       Impact factor: 1.547

3.  Small cell carcinoma of the head and neck: An analysis of the National Cancer Database.

Authors:  Kelli B Pointer; Huaising C Ko; Jeffrey V Brower; Matthew E Witek; Randall J Kimple; Ricardo V Lloyd; Paul M Harari; Andrew M Baschnagel
Journal:  Oral Oncol       Date:  2017-04-25       Impact factor: 5.337

4.  Extrapulmonary small cell carcinoma.

Authors:  E Galanis; S Frytak; R V Lloyd
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

5.  A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx.

Authors:  Jennifer Chapman-Fredricks; Merce Jorda; Carmen Gomez-Fernandez
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-05

6.  Nasopharyngeal neuroendocrine carcinoma: a case report.

Authors:  Ali Reza Mohebbi; Ahmad Daneshi; Ali Reza Emami
Journal:  Ear Nose Throat J       Date:  2008-12       Impact factor: 1.697

7.  Small cell carcinoma of the nasopharynx.

Authors:  I-Hung Lin; Chung-Feng Hwang; Hsiu-Yu Huang; Chih-Yen Chien
Journal:  Acta Otolaryngol       Date:  2007-02       Impact factor: 1.494

8.  Small cell carcinoma of the head and neck: the university of Miami experience.

Authors:  Georges F Hatoum; Brandon Patton; Cristiane Takita; May Abdel-Wahab; Kelly LaFave; Donald Weed; Isildinha M Reis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-10       Impact factor: 7.038

9.  High Grade (Large Cell) Neuroendocrine Carcinoma of the Nasopharynx: Novel Case Report with Touch Preparation Cytology and Positive EBV Encoded Early RNA.

Authors:  Charles D Sturgis; Brian B Burkey; Suhael Momin; Aaron P Hoschar
Journal:  Case Rep Pathol       Date:  2015-05-10

10.  Small cell neuroendocrine carcinoma of the nasopharynx: a rare case report.

Authors:  Daniela Azevedo; Elisabete Rios; Lurdes Vendeira; Cristina Sarmento
Journal:  Autops Case Rep       Date:  2017-03-30
View more
  2 in total

1.  Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.

Authors:  Ying-Peng Peng; Qiao-Dan Liu; Yu-Jing Lin; Shun-Li Peng; Rong Wang; Xi-Wei Xu; Wei Wei; Gui-Hua Zhong; Yu-Ling Zhou; Ya-Qin Zhang; Ye Liu; Si-Yang Wang; Hai-Yu Hong; Zhi-Gang Liu
Journal:  Radiat Oncol       Date:  2021-10-11       Impact factor: 3.481

2.  Clinical Characteristics and Prognosis of Small Cell Carcinoma in the Nasopharynx: A Population-Based Study.

Authors:  Yu-Ling Zhou; Ying-Peng Peng; Qiao-Dan Liu; Xian-Zhen Chen; Jianzhong He; Wei Wei; Gui-Hua Zhong; Ya-Qin Zhang; Ye Liu; Jia-Ying Pan; Shao-Yan Feng; Zhi-Gang Liu
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.